Dong-A ST Launches Darbecron in UAE
'Darbecron (project name DA-3880),' a second-generation anemia treatment biosimilar developed by Dong-A ST, has been officially launched in the United Arab Emirates (UAE) market.Dong-A ST announced on Oct. 12 local time that it launched Darbecron, a darbepoetin alfa-based biosimilar, in the UAE. Pre
We haven't written up this one. BusinessKorea has the full story — the link below goes straight to it.